Invention Grant
US09408381B2 Alpha Connexin c-Terminal (ACT) peptides for use in transplant
有权
用于移植的α连接蛋白c-terminal（ACT）肽
- Patent Title: Alpha Connexin c-Terminal (ACT) peptides for use in transplant
- Patent Title (中): 用于移植的α连接蛋白c-terminal（ACT）肽
-
Application No.: US14932630Application Date: 2015-11-04
-
Publication No.: US09408381B2Publication Date: 2016-08-09
- Inventor: Gautam Ghatnekar , Robert Gourdie , Jane Jourdan
- Applicant: MUSC Foundation for Research Development
- Applicant Address: US SC Charleston
- Assignee: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
- Current Assignee: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
- Current Assignee Address: US SC Charleston
- Agency: Cooley LLP
- Main IPC: C07K7/06
- IPC: C07K7/06 ; C07K14/47 ; A01N1/02
Abstract:
The present disclosure provides compositions and methods for treating or preventing macular degeneration in a subject. The disclosure also provides compositions and methods for preserving organs and tissues for transplantation, and for preventing cellular injury in organs or in subjects.
Public/Granted literature
- US20160120171A1 ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES FOR USE IN TRANSPLANT Public/Granted day:2016-05-05
Information query
